BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6117168)

  • 21. Recombinant interferon alpha-2b in patients with metastatic apudomas: effect on tumours and tumour markers.
    Biesma B; Willemse PH; Mulder NH; Verschueren RC; Kema IP; de Bruijn HW; Postmus PE; Sleijfer DT; de Vries EG
    Br J Cancer; 1992 Nov; 66(5):850-5. PubMed ID: 1384643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pancreatic-polypeptide (PP) and endocrine tumours of the pancreas.
    Schwartz TW
    Scand J Gastroenterol Suppl; 1979; 53():93-100. PubMed ID: 225793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding of antibodies against human prealbumin to intestinal and bronchial carcinoids and to pancreatic endocrine tumours.
    Bussolati G; Papotti M; Sapino A
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1984; 45(1):15-22. PubMed ID: 6142557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumors of the endocrine pancreas.
    Friesen SR
    N Engl J Med; 1982 Mar; 306(10):580-90. PubMed ID: 6120456
    [No Abstract]   [Full Text] [Related]  

  • 25. [Ectopic production of chorionic gonadotropin in apudomas (author's transl)].
    Seif FJ; Scherbaum W; Sadowski P; Heni F; Kruz-Isler G
    Dtsch Med Wochenschr; 1978 Feb; 103(6):253-4, 257-9. PubMed ID: 203438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human chorionic gonadotropin alpha-subunit in endocrine cells of fibrotic and neoplastic lung. Its mode of localization and the size profile of granules.
    Fukayama M; Hayashi Y; Shiozawa Y; Furukawa E; Funata N; Koike M
    Lab Invest; 1990 Apr; 62(4):444-51. PubMed ID: 2159084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Endocrinologic studies of tumors of Langerhans Islands].
    Yamaguchi K; Abe K
    Nihon Rinsho; 1980; 38(1):30-8. PubMed ID: 6248656
    [No Abstract]   [Full Text] [Related]  

  • 28. [Are chorionic gonadotropin (HCG) and its alpha and beta subunits useful markers in non-trophoblastic tumors?].
    Franchimont P; Collette J; Hustin J; Zangerle PF; Reuter A; Vrindts Y
    Ann Endocrinol (Paris); 1984; 45(4-5):235-41. PubMed ID: 6085536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative study of seven neuroendocrine markers in pancreatic endocrine tumours.
    Bordi C; Pilato FP; D'Adda T
    Virchows Arch A Pathol Anat Histopathol; 1988; 413(5):387-98. PubMed ID: 2845642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostaglandins E and F in endocrine diarrheagenic syndromes.
    Jaffe BM; Condon S
    Ann Surg; 1976 Oct; 184(4):516-24. PubMed ID: 189708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Argyrophil cell hyperplasia and a carcinoid tumour in the stomach of a patient with sporadic Zollinger-Ellison syndrome.
    Feurle GE
    Gut; 1994 Feb; 35(2):275-7. PubMed ID: 8307483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Eutopic and ectopic production of glycoprotein hormones alpha and beta subunits].
    Bidart JM; Baudin E; Troalen F; Bellet D; Schlumberger M
    Ann Endocrinol (Paris); 1997; 58(2):125-8. PubMed ID: 9239230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Gastro-entero-pancreatic endocrine system neoplasms (pancreatic endocrine system neoplasms)].
    Matsuo Y
    Nihon Rinsho; 1976 Oct; 34(10):2987-93. PubMed ID: 187813
    [No Abstract]   [Full Text] [Related]  

  • 34. Production of immunoreactive corticotropin-releasing hormone in various neuroendocrine tumors.
    Tsuchihashi T; Yamaguchi K; Abe K; Yanaihara N; Saito S
    Jpn J Clin Oncol; 1992 Aug; 22(4):232-7. PubMed ID: 1359172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endocrine tumors of the pancreas and their clinical syndromes.
    Kaplan EL; Michelassi F
    Surg Annu; 1986; 18():181-223. PubMed ID: 3001955
    [No Abstract]   [Full Text] [Related]  

  • 36. [Endocrine active pancreatic neoplasms].
    Largiadèr F
    Helv Chir Acta; 1978 Jan; 44(5-6):747-56. PubMed ID: 24021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ectopic production of human chorionic gonadotropin in malignant tumors.
    Hattori M; Fukase M; Yoshimi H; Matsukura S; Imura H
    Cancer; 1978 Nov; 42(5):2328-33. PubMed ID: 719611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of primary and secondary peptides with somatostatin analog in the therapy of functional endocrine tumors.
    Woltering EA; Mozell EJ; O'Dorisio TM; Fletcher WS; Howe B
    Surg Gynecol Obstet; 1988 Dec; 167(6):453-62. PubMed ID: 2460958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MEN type 1 associated with mediastinal carcinoid producing parathyroid hormone, calcitonin and chorionic gonadotropin.
    Takayama T; Kameya T; Inagaki K; Nonaka M; Miyazawa H; Ogawa N; Yano M; Morita T; Arai T; Niino S
    Pathol Res Pract; 1993 Nov; 189(9):1090-6; discussion 1096-100. PubMed ID: 7905624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Co-expression of ghrelin and its receptor in pancreatic endocrine tumours.
    Ekeblad S; Lejonklou MH; Grimfjärd P; Johansson T; Eriksson B; Grimelius L; Stridsberg M; Stålberg P; Skogseid B
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):115-22. PubMed ID: 17201810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.